Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device User Fee Advocate Gregg To Assume Senate HELP Chairmanship

This article was originally published in The Gray Sheet

Executive Summary

FDA's ability to adhere to device user fee performance goals will be closely monitored in the 108th Congress under a Senate HELP Committee led by Sen. Judd Gregg (R-N.H.)

You may also be interested in...



Senate Approves Vincent Ventimiglia As HHS Top Legislative Official

HHS legislative operations are now headed by Vince Ventimiglia, who brings to the post several years experience as a Senate staff member plus a stint directing the government affairs shop of Medtronic

Senate Approves Vincent Ventimiglia As HHS Top Legislative Official

HHS legislative operations are now headed by Vince Ventimiglia, who brings to the post several years experience as a Senate staff member plus a stint directing the government affairs shop of Medtronic

GPO Reform, Industry Consolidation Trends Are On MDMA 2003 Agenda

Masimo's decision not to renew its AdvaMed membership in 2003 reflects a groundswell of discontent among some small businesses who must pay a fee for 510(k)s under MDUFMA but will experience no significant improvement in review times

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel